BAM
CRDF icon

Blueshift Asset Management’s Cardiff Oncology CRDF Stock Holding History

Blueshift Asset Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,487
Closed -$134K – 951
2021
Q1 		$134K Buy
+14,487
New +$176K 0.01% 803

Other funds holding CRDF

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Blueshift Asset Management's CRDF Position: Q2 2021 in Review

Blueshift Asset Management sold out of Cardiff Oncology (CRDF) in Q2 2021, closing a stake of 14,487 shares — an estimated $134K sold.

Blueshift Asset Management first reported a position in CRDF in Q1 2021 and held it in 1 quarter. The position peaked at $134K in Q1 2021. 90 funds tracked by Wall St. Rank hold CRDF as of Q2 2021.

  • Blueshift Asset Management reported no remaining Cardiff Oncology position as of Q2 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 14,487 Cardiff Oncology shares in Q2 2021, an estimated $134K.
  • Blueshift Asset Management first reported a position in Cardiff Oncology in Q1 2021 and held it in 1 quarter.
  • Blueshift Asset Management's Cardiff Oncology position peaked at $134K in Q1 2021.
  • 90 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2021.

Based on Blueshift Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.